Artificial Intelligence (AI) in Genomics Market

Artificial Intelligence (AI) in Genomics Market, By Delivery Mode, By Functionality, By Application, By End User, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Artificial intelligence (AI) techniques offer great potential for advancing genomic medicine. The AI techniques machine learning and deep learning, a type of machine learning offer new computational approaches to streamlining key analytical problems in genomic medicine

Market Dynamics:

Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics, Growing Adoption of Ai-Based Solutions, and Increased Biomedical and Genomic Datasets are major factors expected to augment growth of the global artificial intelligence (ai) in genomics market over the forecast period.

For instance, in November 2020, BioMarin Pharmaceutical Inc., and Deep Genomics announced that the companies have entered into a preclinical collaboration that will use Deep Genomics artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications with high unmet need.

Key features of the study:

• This report provides in-depth analysis of the global artificial intelligence (ai) in genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence (ai) in genomics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Fabric Genomics, International Business Machines, Microsoft, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, Diploid, and among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence (AI) in genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (ai) in genomics market.

Detailed Segmentation:

• Global Artificial Intelligence (AI) in Genomics Market, By Delivery Mode:
• On-Premises
• Cloud-Based
• Global Artificial Intelligence (AI) in Genomics Market, By Functionality:
• Genome Sequencing
• Gene Editing
• Others
• Global Artificial Intelligence (AI) in Genomics Market, By Application:
• Translational Precision Medicine
• Clinical & Genomic Diagnostics
• Others Applications
• Global Artificial Intelligence (AI) in Genomics Market, By End User:
• Pharma & Biotech Companies
• Public & Consumer Genomic Center
• Others
• Global Artificial Intelligence (AI) in Genomics Market, By Geography:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles:
• Fabric Genomics
• International Business Machines
• MICROSOFT
• NVIDIA
• AI Therapeutics
• Ares Genetics
• Benevolent AI
• Deep Genomics
• Diploid